Related Experiment Video
Updated: Nov 1, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long non-coding RNAs: A view to kill ovarian cancer
Alexey V Zamaraev1, Pavel I Volik1, Gennady T Sukhikh2
1Faculty of Medicine, MV Lomonosov Moscow State University, 119991 Moscow, Russia.
Abstract:
An emerging role of long non-coding RNAs (lncRNAs) in tumor progression has been revealed in the last decade. Through interactions with nucleic acids and proteins, lncRNAs could act as enhancers, scaffolds or decoys for a number of oncoproteins and tumor suppressors. The aberrant lncRNA expression or mutations are often associated with changes in a variety of cellular processes, including proliferation, stress response and cell death. Here, we will focus on the tumor-associated lncRNAs in ovarian cancer according to their contribution to cancer hallmarks, such as intense proliferation, cell death resistance, altered energy metabolism, invasion and metastasis, and immune evasion. Moreover, the potential clinical implications of lncRNAs and their significance for the diagnosis, prognosis and therapy of ovarian cancer will be discussed.
Insights
Long non-coding RNAs (lncRNAs) play a key role in ovarian cancer progression. Understanding lncRNA functions in cancer hallmarks is crucial for developing new diagnostic and therapeutic strategies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- lncRNAs can modulate gene expression and protein activity, influencing tumor development.
Purpose of the Study:
- To review the role of tumor-associated lncRNAs in ovarian cancer.
- To discuss lncRNA contributions to cancer hallmarks like proliferation, metastasis, and immune evasion.
- To explore the clinical significance of lncRNAs for ovarian cancer diagnosis, prognosis, and therapy.
Main Methods:
- Literature review and synthesis of existing research on lncRNAs in ovarian cancer.
Main Results:
- lncRNAs are implicated in key ovarian cancer hallmarks, including intense proliferation, resistance to cell death, altered metabolism, invasion, metastasis, and immune evasion.
- Aberrant lncRNA expression or mutations are linked to dysregulation of cellular processes in ovarian cancer.
Conclusions:
- Tumor-associated lncRNAs represent promising biomarkers and therapeutic targets for ovarian cancer.
- Further research into lncRNA mechanisms can advance ovarian cancer diagnostics and treatment strategies.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
MicroRNAs
MicroRNAs